Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance

por Cheng, Han-Ying, Hsieh, Chia-Hsin, Lin, Po-Han, Chen, Yu-Tung, Hsu, Dennis Shin-Shian, Tai, Shyh-Kuan, Chu, Pen-Yuan, Yang, Muh-Hwa
Publicado 2022

A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer

por Chung, Shin-Yi, Chang, Yu-Chan, Hsu, Dennis Shin-Shian, Hung, Ya-Chi, Lu, Meng-Lun, Hung, Yi-Ping, Chiang, Nai-Jung, Yeh, Chun-Nan, Hsiao, Michael, Soong, John, Su, Yeu, Chen, Ming-Huang
Publicado 2022

Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway

por Chung, Shin-Yi, Hung, Yi-Ping, Pan, Yi-Ru, Chang, Yu-Chan, Wu, Chiao-En, Hsu, Dennis Shin-Shian, Chang, Peter Mu-Hsin, Lu, Meng-Lun, Huang, Chi-Ying F., Su, Yeu, Hsiao, Michael, Yeh, Chun-Nan, Chen, Ming-Huang
Publicado 2021

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy

por Tan, Kien Thiam, Yeh, Chun-Nan, Chang, Yu-Chan, Cheng, Jen-Hao, Fang, Wen-Liang, Yeh, Yi-Chen, Wang, Yu-Chao, Hsu, Dennis Shin-Shian, Wu, Chiao-En, Lai, Jiun-I, Chang, Peter Mu-Hsin, Chen, Ming-Han, Lu, Meng-Lun, Chen, Shu-Jen, Chao, Yee, Hsiao, Michael, Chen, Ming-Huang
Publicado 2020